FDA Inspection
Emcure Pharmaceuticals LimitedEmcure Pharmaceuticals Limited – FDA Inspection, Aug 17, 2017
Record Details
This FDA Inspection record concerns Emcure Pharmaceuticals Limited, with an inspection on August 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Jay Jariwala (Issuing Officer)
- Massoud Motamed (FDA Associated Person)
- Thomas J. Arista
View Company Profile
ID · d554a313-6947-4b22-9ae7-7216bedcd7f0
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1023101
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Emcure Pharmaceuticals Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 20, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 4, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Emcure Pharmaceuticals Limited
- FDA Inspection 1079858 - 2019-02-20
- FDA Inspection 1075227 - 2018-10-30
- FDA Inspection 912371 - 2015-02-04
- FDA Inspection 867389 - 2014-02-07
- FDA Inspection 834734 - 2013-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.